Results 181 to 190 of about 3,654 (190)

Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis

Clinical Gastroenterology and Hepatology, 2017
Maria Stepanova, Graham R Foster, Alessandra Mangia   +2 more
exaly  

Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C

Expert Opinion on Drug Metabolism and Toxicology, 2017
Vincent Soriano, Laura Benítez-Gutiérrez, Ana Arias   +2 more
exaly  

Novel determination of sofosbuvir and velpatasvir in human plasma by UPLC–MS/MS method: Application to a bioequivalence study

Biomedical Chromatography, 2018
Mamdouh R Rezk, Emad B Basalious, Kamal A Badr   +2 more
exaly  

Sofosbuvir and velpatasvir for the treatment of hepatitis C

Expert Review of Gastroenterology and Hepatology, 2017
exaly  

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2020
openaire   +1 more source

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2019
openaire   +1 more source

Sofosbuvir/Velpatasvir Concentrations in the Breastmilk of Postpartum Women With Opioid Use Disorder Receiving Treatment for Hepatitis C Virus: A Pharmacokinetic Study

Clinical Infectious Diseases
Jennifer J Kiser, Brandon Klein, Lane Bushman   +2 more
exaly  

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2019
openaire   +1 more source

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2018
openaire   +1 more source

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly
openaire   +2 more sources